Leica Biosystems

From Wikipedia, the free encyclopedia
Leica Biosystems
Company typeSubsidiary GmbH
IndustryBiotechnology, Digital pathology
Founded1989
HeadquartersWetzlar, Germany
Key people
Markus Lusser
ProductsMicrotome; Cryostat; Vibratome
ParentDanaher Corporation
Websitewww.leicabiosystems.com

Leica Biosystems (founded 1989) is a medical devices company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company as well as a division of Danaher Corporation.

Company Description[edit]

The company has headquarters in Germany with operations in the United Kingdom, Ireland, Netherlands, Bulgaria, Australia, India, China, Singapore, Mexico and the United States (California, Illinois, Massachusetts and Ohio). A research and development facility concentrating on companion diagnostics for cancer drugs has been in operation in Danvers, Massachusetts since August 2012.[1]

The Massachusetts facility has partnered with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.[2]

Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012.[3] In October 2014, the company announced they will purchase Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies.[4]

The company partners with Mayo Clinic’s Department of Laboratory Medicine and Pathology in developing cytogenetics imaging software.[5]

References[edit]

  1. ^ Seiffert, Don. “Leica Biosystems plans to expand R&D facility in Mass.” Boston Business Journal. Feb. 1, 2013
  2. ^ Weintraub, Karen. “Leica Biosystems plans R&D expansion in area.” The Boston Globe. Feb. 25, 2013
  3. ^ “Leica Biosystems completes acquisition of Aperio.” Yahoo Finance. Oct. 24, 2012
  4. ^ Collins, Allison. “Leica Biosystems Adds GTCR-Backed Devicor Medical Products.” Mergers and Acquisitions. Oct. 28, 2014
  5. ^ “Leica Biosystems and Mayo Clinic Collaborate on Future of Cytogenetics Imaging.” Mayo Clinic Blog. December 15, 2014

See also[edit]